Modified Gompertz equation for electrotherapy murine tumor growth kinetics: predictions and new hypotheses
- PMID: 21029411
- PMCID: PMC2988748
- DOI: 10.1186/1471-2407-10-589
Modified Gompertz equation for electrotherapy murine tumor growth kinetics: predictions and new hypotheses
Abstract
Background: Electrotherapy effectiveness at different doses has been demonstrated in preclinical and clinical studies; however, several aspects that occur in the tumor growth kinetics before and after treatment have not yet been revealed. Mathematical modeling is a useful instrument that can reveal some of these aspects. The aim of this paper is to describe the complete growth kinetics of unperturbed and perturbed tumors through use of the modified Gompertz equation in order to generate useful insight into the mechanisms that underpin this devastating disease.
Methods: The complete tumor growth kinetics for control and treated groups are obtained by interpolation and extrapolation methods with different time steps, using experimental data of fibrosarcoma Sa-37. In the modified Gompertz equation, a delay time is introduced to describe the tumor's natural history before treatment. Different graphical strategies are used in order to reveal new information in the complete kinetics of this tumor type.
Results: The first stage of complete tumor growth kinetics is highly non linear. The model, at this stage, shows different aspects that agree with those reported theoretically and experimentally. Tumor reversibility and the proportionality between regions before and after electrotherapy are demonstrated. In tumors that reach partial remission, two antagonistic post-treatment processes are induced, whereas in complete remission, two unknown antitumor mechanisms are induced.
Conclusion: The modified Gompertz equation is likely to lead to insights within cancer research. Such insights hold promise for increasing our understanding of tumors as self-organizing systems and, the possible existence of phase transitions in tumor growth kinetics, which, in turn, may have significant impacts both on cancer research and on clinical practice.
Figures










References
-
- Cotran RS, Kumar V, Collins T. Sexta Edición. McGraw-Hill- Interamericana de España, S.A. U. Madrid; 1999. Patología Estructural y Funcional; pp. 277–347.
-
- Bellomo N, Li NK, Maini PK. On the foundations of cancer modeling: selected topics, speculations, and perspectives. Math Mod Meth Appl Sci. 2008;18:593–646. doi: 10.1142/S0218202508002796. - DOI
-
- Stein WD, Figg WD, Dahut W, Stein AD, Hoshen MB, Price D, Bates SE, Fojo T. Tumor Growth Rates Derived from Data for Patients in a Clinical Trial Correlate Strongly with Patient Survival: A Novel Strategy for Evaluation of Clinical Trial Data. The Oncologist. 2008;13:1046–1054. doi: 10.1634/theoncologist.2008-0075. - DOI - PMC - PubMed
-
- González MJ, Herrera FL, Miranda-Massari JM, Guzmán AM, Riordan NH, Ricart CM. Tumor growth parameters of in-vivo human breast carcinoma: a proposed mathematical model for tumor growth kinetics. P R Health Sci J. 2006;25:71–73. - PubMed
-
- Preziosi L. Cancer Modeling and Simulation. Chapman & Hall/CRC Mathematical Biology and Medicine Series. 2003.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources